Cargando…

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance

BACKGROUND: Acute myeloid leukemia (AML) remains a devastating disease with a 5-year survival rate of less than 30%. AML treatment has undergone significant changes in recent years, incorporating novel targeted therapies along with improvements in allogeneic bone marrow transplantation techniques. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levin, May, Stark, Michal, Ofran, Yishai, Assaraf, Yehuda G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809753/ https://www.ncbi.nlm.nih.gov/pubmed/33446189 http://dx.doi.org/10.1186/s12935-021-01746-w

Ejemplares similares

The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity
por: Levin, May, et al.
Publicado: (2018)

Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine
por: Levin, May, et al.
Publicado: (2019)

Folylpolyglutamate synthetase mRNA G-quadruplexes regulate its cell protrusion localization and enhance a cancer cell invasive phenotype upon folate repletion
por: Stark, Michal, et al.
Publicado: (2023)

Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence
por: Stemer, Galia, et al.
Publicado: (2021)

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
por: Ramani, Vishnu C., et al.
Publicado: (2015)

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
por: Shumilov, Evgenii, et al.
Publicado: (2021)

Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells
por: Stark, Michal, et al.
Publicado: (2017)

Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
por: Fajardo-Orduña, Guadalupe Rosario, et al.
Publicado: (2021)

Two predictive precision medicine tools for hepatocellular carcinoma
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics
por: Goler-Baron, Vicky, et al.
Publicado: (2012)

Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia
por: Raz, Shachar, et al.
Publicado: (2014)

Genetic Stratification in Myeloid Diseases: From Risk Assessment to Clinical Decision Support Tool
por: Ofran, Yishai
Publicado: (2014)

Daratumumab: new indications revolving around "off-targets"
por: Ofran, Yishai
Publicado: (2021)

A chemotherapy-free regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia: are we there yet?
por: Ofran, Yishai
Publicado: (2021)

Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023)

The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
por: Stark, Michal, et al.
Publicado: (2020)

Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
por: Niu, Chang-Chun, et al.
Publicado: (2014)

Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
por: Lai, Weixin, et al.
Publicado: (2021)

Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage
por: Niu, Li-Ting, et al.
Publicado: (2021)

miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor
por: Iida, Keiichiro, et al.
Publicado: (2013)

RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition
por: Rubio, María Fernanda, et al.
Publicado: (2017)

Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation
por: Luo, Xiaodan, et al.
Publicado: (2019)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
por: Jelly, Neil D, et al.
Publicado: (2012)

Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017)

Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance
por: Zhang, Wei, et al.
Publicado: (2020)

How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia
por: Frisch, Avraham, et al.
Publicado: (2019)

Precision medicine in the treatment stratification of AML patients: challenges and progress
por: Lohse, Ines, et al.
Publicado: (2018)

The Fhit protein: an opportunity to overcome chemoresistance
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML
por: Shi, Li, et al.
Publicado: (2013)

β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells
por: Bar-Zeev, Maya, et al.
Publicado: (2016)

Nanos3, a cancer-germline gene, promotes cell proliferation, migration, chemoresistance, and invasion of human glioblastoma
por: Zhang, Fengyu, et al.
Publicado: (2020)

Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine
por: Guo, Chong, et al.
Publicado: (2020)

KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
por: Chen, Hong, et al.
Publicado: (2016)

Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway
por: Wu, Zhaojia, et al.
Publicado: (2019)

A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
por: Zhang, Dengke, et al.
Publicado: (2022)

JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4
por: Jing, Chao, et al.
Publicado: (2021)

Favorable outcomes of NPM1(mut) AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
por: Khan, I., et al.
Publicado: (2023)

Early death in acute promyelocytic leukemia: time to redefine risk groups
por: Salman, Meira Yisraeli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kdpl1fbt5nl27h3ipi4e7elc2d